X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (76) 76
index medicus (75) 75
microbiology (71) 71
infectious diseases (41) 41
pharmacology & pharmacy (35) 35
tuberculosis (29) 29
female (28) 28
male (28) 28
anti-bacterial agents - pharmacology (26) 26
microbial sensitivity tests (25) 25
bacteria (23) 23
mutation (23) 23
life sciences (21) 21
molecular sequence data (20) 20
bacterial infections and mycoses (19) 19
adult (17) 17
dna, bacterial - genetics (17) 17
drug resistance, bacterial (17) 17
antibiotics (16) 16
biochemical phenomena, metabolism, and nutrition (16) 16
drug resistance, bacterial - genetics (16) 16
middle aged (16) 16
nontuberculous mycobacteria (16) 16
polymerase chain reaction (16) 16
aged (15) 15
drug resistance (15) 15
escherichia-coli (15) 15
quinolones (15) 15
dna gyrase - genetics (14) 14
leprosy (14) 14
quinolones - pharmacology (14) 14
anti-bacterial agents - therapeutic use (13) 13
dna gyrase (13) 13
mycobacterium tuberculosis - drug effects (13) 13
infectious disease (12) 12
microbiology and parasitology (12) 12
mycobacterium tuberculosis (12) 12
susceptibility (12) 12
antitubercular agents - pharmacology (11) 11
bacteriology (11) 11
base sequence (11) 11
diagnosis (11) 11
gene (11) 11
identification (11) 11
infection (11) 11
infections (11) 11
mycobacterium - genetics (11) 11
prevalence (11) 11
risk factors (11) 11
sequence analysis, dna (11) 11
animals (10) 10
bacterial proteins - genetics (10) 10
drug resistance in microorganisms (10) 10
epidemiology (10) 10
genetic aspects (10) 10
health aspects (10) 10
klebsiella-pneumoniae (10) 10
mechanisms of resistance (10) 10
microbial sensitivity tests - methods (10) 10
mycobacterium - drug effects (10) 10
mycobacterium infections, nontuberculous - microbiology (10) 10
rapidly growing mycobacteria (10) 10
research (10) 10
resistance (10) 10
dna, bacterial - chemistry (9) 9
enterobacteriaceae infections - microbiology (9) 9
france (9) 9
genes (9) 9
genotype (9) 9
immunology (9) 9
mutations (9) 9
mycobacterium tuberculosis - enzymology (9) 9
amino acid sequence (8) 8
care and treatment (8) 8
clarithromycin (8) 8
dna gyrase - metabolism (8) 8
drug-resistance (8) 8
escherichia coli - genetics (8) 8
fluoroquinolones (8) 8
genes, bacterial (8) 8
human health and pathology (8) 8
mediated quinolone resistance (8) 8
mycobacteria (8) 8
mycobacterium - classification (8) 8
mycobacterium tuberculosis - genetics (8) 8
pcr (8) 8
prospective studies (8) 8
young adult (8) 8
analysis (7) 7
anti-infective agents - pharmacology (7) 7
ciprofloxacin (7) 7
drug therapy (7) 7
enterobacteriaceae (7) 7
escherichia coli - drug effects (7) 7
fluoroquinolone resistance (7) 7
fluoroquinolones - pharmacology (7) 7
france - epidemiology (7) 7
in-vitro (7) 7
mycobacteriology and aerobic actinomycetes (7) 7
mycobacterium (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 11/2017, Volume 43, Issue 11, pp. 1613 - 1625
Microbiological diagnosis (MD) of infections remains insufficient. The resulting empirical antimicrobial therapy leads to multidrug resistance and... 
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Sepsis | Anesthesiology | Aetiological source | Bacteremia | PCR | DIAGNOSIS | COST-EFFECTIVENESS | GUIDELINES | NEUTROPENIC PATIENTS | DE-ESCALATION | DISEASES SOCIETY | SEPTIC SHOCK | BLOOD-STREAM INFECTIONS | EPIDEMIOLOGY | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Endocarditis - blood | Febrile Neutropenia - mortality | Humans | Middle Aged | Sepsis - diagnosis | Intensive Care Units - statistics & numerical data | Male | Molecular Diagnostic Techniques - economics | Time-to-Treatment - economics | Anti-Bacterial Agents - therapeutic use | Endocarditis - diagnosis | Time Factors | Endocarditis - mortality | Female | Retrospective Studies | Febrile Neutropenia - diagnosis | Hospital Mortality | Risk Factors | Sepsis - mortality | Cross-Over Studies | Febrile Neutropenia - blood | Quality Improvement | Cost-Benefit Analysis | Intention to Treat Analysis | Aged | Sepsis - blood | Diagnosis | Health aspects | Endocarditis | Health care | Intervention | Pathogens | Multidrug resistance | Infections | Clustering | Patients | Empirical analysis | Blood | Confidence intervals | Randomization | Multilevel | Clusters | Diagnostic systems | Cost analysis | Neutropenia | Life Sciences | Microbiology and Parasitology | Mycology | Original
Journal Article
Science, ISSN 0036-8075, 1/2005, Volume 307, Issue 5707, pp. 223 - 227
The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been... 
Antibacterials | Mycobacterium tuberculosis | Lungs | Half lives | Antituberculars | Multidrug resistant tuberculosis | Infections | Dosage | Bacterial load | Pharmacokinetics | Research Article | ANTITUBERCULOSIS AGENTS | MULTIDISCIPLINARY SCIENCES | Antitubercular Agents - chemistry | Humans | Drug Resistance, Bacterial | Molecular Sequence Data | Male | Tuberculosis - microbiology | Mycobacterium tuberculosis - drug effects | Quinolines - pharmacology | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Tuberculosis, Multidrug-Resistant - microbiology | Enzyme Inhibitors - chemistry | Tuberculosis - drug therapy | Bacterial Proton-Translocating ATPases - antagonists & inhibitors | Drug Evaluation, Preclinical | Drug Therapy, Combination | Mycobacterium smegmatis - enzymology | Antitubercular Agents - therapeutic use | Amino Acid Sequence | Mycobacterium smegmatis - growth & development | Bacterial Proton-Translocating ATPases - chemistry | Bacterial Proton-Translocating ATPases - metabolism | Quinolines - chemistry | Antitubercular Agents - pharmacology | Enzyme Inhibitors - pharmacology | Enzyme Inhibitors - therapeutic use | Point Mutation | Animals | Antitubercular Agents - pharmacokinetics | Mycobacterium tuberculosis - enzymology | Mycobacterium smegmatis - drug effects | Diarylquinolines | Mice | Protein Subunits - antagonists & inhibitors | Protein Subunits - chemistry | Quinolines - therapeutic use | Mycobacterium tuberculosis - growth & development | Tuberculosis, Multidrug-Resistant - drug therapy | Care and treatment | Usage | Tuberculosis | Respiratory agents | Research | Adenosine triphosphatase | Clinical trials | Drug resistance
Journal Article